India's Natco Pharma jumps on approval for diabetes drug in India

Natco Pharma

16/02/2026 05:23

** Natco Pharma NATP.NS jumps ~11% to 913 rupees

** Pharma co gets Indian drug regulator's approval to manufacture and market generic semaglutide injection in country; injection used to treat type-2 diabetes mellitus, manage weight

** Product launch likely in March

** Trading volume at more than 8x the 30-day average

** YTD, NATP up ~1% vs ~2% fall in Nifty 500 index .NIFTY500

 (Reporting by Vijay Malkar)

 ((VijayDattaram.Malkar@thomsonreuters.com;))